Oral HCFU for prevention of hepatic metastasis in an experimental colorectal carcinoma

Anticancer Research

Volumn 21, Issue 2 A, 2001, Pages 899-904

  Ito, K ^a   Wang, L ^a   Ye, C ^a   Ando, H ^a   Hibi, K ^a   Hidemura, K ^a   Akiyama, S ^a   Kasai, Y ^a   Nakao, A ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon26 cancer cells; Colorectal cancer; HCFU; Hepatic metastasis

Indexed keywords

CARMOFUR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; LIVER METASTASIS; LIVER WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; LIVER; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; ORGAN SIZE; SURVIVORS;

EID: 0035024840     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fluorouracil as an adjuvant to surgery in carcinoma of the colon
2. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer
3. Intraportal Chemotherapy in colorectal carcinoma as an adjuvant modality
4. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
5. Prospective adjuvant chemotherapy of mitomycin C plus HCFU for colorectal cancer(2nd report) -6 year- survival after surgery
6. Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results from the Cooperative Project No. 7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer
7. Fluorouracil: Biochemistry and pharmacology
8. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program study
9. Anti tumor activity of 1-hexylcarbamoyl-5- fluorouracil in a variety of experimental tumors
10. 1-Hexylcarbamoyl-5-fluorinated pyrimidine
11. Adjuvant therapy for patients with colon and rectal cancer; summary of NIH consensus statement
12. Prospective adjuvant therapy with Mitomycin C and Carmofur (HCFU) for colorectal cancer: Ten years follow up
13. Oral adjuvant chemotherapy with Carmofur(HCFU) for colorectal cancer: Five years follow up
14. Effect of oral adjuvant therapy with Carmofur for distant metastasis of colorectal cancer
15. Accelerated growth rates of recurrent hepatocelluar carcinoma after liver transplantation